about
Development and implementation of PROgmatic: A clinical trial management system for pragmatic multi-centre trials, optimised for electronic data capture and patient-reported outcomes.Quality of life in the Danish general population--normative data and validity of WHOQOL-BREF using Rasch and item response theory models.Tests of data quality, scaling assumptions, and reliability of the Danish SF-36.Confirmatory factor analysis of the thyroid-related quality of life questionnaire ThyPRO.Increased risk of long-term sickness absence, lower rate of return to work, and higher risk of unemployment and disability pensioning for thyroid patients: a Danish register-based cohort studyAnxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre.Assessing health-related quality of life in patients with benign non-toxic goitre.Fatigue in the Danish general population. Influence of sociodemographic factors and disease.Thyroid-specific questions on work ability showed known-groups validity among Danes with thyroid diseases.Disease-Specific as Well as Generic Quality of Life Is Widely Impacted in Autoimmune Hypothyroidism and Improves during the First Six Months of Levothyroxine Therapy.Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST).Quality of life in patients with benign thyroid disorders. A review.Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trialIs Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial.Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.Quality of life in patients with benign nontoxic goiter: impact of disease and treatment response, and comparison with the general population.High Level of Agreement between Electronic and Paper Mode of Administration of a Thyroid-Specific Patient-Reported Outcome, ThyPRO.Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.Development of a Short Version of the Thyroid-Related Patient-Reported Outcome ThyPRO.Quality of life after thyroidectomy in patients with nontoxic nodular goiter: A prospective cohort study.Few items in the thyroid-related quality of life instrument ThyPRO exhibited differential item functioning.Quality of life, anxiety and depression symptoms in early and late pregnancy in women with pregestational diabetes.Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO.Mental health in early pregnancy is associated with pregnancy outcome in women with pregestational diabetes.Conversion of standard retrospective patient-reported outcomes to momentary versions: cognitive interviewing reveals varying degrees of momentary compatibility.ThyPROpl--The Polish version of the thyroid-specific quality of life questionnaire ThyPRO.The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects.Posttraumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12 months after injury.Dimensions of post-stroke fatigue: a two-year follow-up study.Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO.Using method triangulation to validate a new instrument (CPWQ-com) assessing cancer patients' satisfaction with communication.Exploring the experiences of people with hypo- and hyperthyroidism.Diabetic patients treated with dialysis: complications and quality of life.Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide complementary perspectives.Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry.Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination.Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing
P50
Q30755609-B39B051C-A99D-467B-B122-71BDC34EB8B5Q30921727-66AC3591-CEFB-44CF-9B03-2973CF8A4995Q31975181-A4C2C18B-DF4D-4F78-A00D-6B96D6AFA2C9Q34233572-8B00A3D5-F103-4C81-864D-F86869AF2987Q34396487-F556BBDA-29CD-4807-AEA9-43866D8FCAB0Q34471998-2CA0D657-7CDD-4F0E-8AC0-3AF5F38FE841Q35210186-4BAA214C-212E-4DD1-90B5-A226537BA298Q35400543-B7A667EF-A83F-47AD-B60B-5290F8549F8FQ35789443-D6DE2EBD-AAFC-4F1E-B253-2F0CCCFFA0E4Q36039289-9BD4DE94-9916-4FDB-B7A6-16CBD5F8130DQ36270288-E4162A22-8927-419C-91D8-674E410172A6Q36429930-4595140A-7E7D-479E-92EF-692155C263A4Q37109006-108C4D06-4986-438D-B96E-A412802E2986Q37290903-4FAAD974-2457-4D84-ACC9-3C8C3C6825E0Q37702377-4CD595CF-1525-4683-AB2D-959419FF159DQ37712630-B43EF59D-96BA-454B-B02B-680671E33270Q38846086-0E6B868C-C85A-4580-B1D3-2635D0FDD0C0Q39053487-6DDFD733-5D04-4BA0-8D95-92F74E47A8BAQ39834789-5CE93FA7-8148-45C2-9C82-DF14E96E5BEFQ40246242-1BCB70C5-D7C4-4452-BA1F-F10C147E2C61Q40692737-3E3C7E67-D798-4FDB-8B44-F668CC08DE9EQ42687880-DB46F05C-AA63-4999-9429-3EE84BD04FBFQ44776566-E2154A57-7608-4556-BED6-564BC13E608DQ47380092-C9F3C659-99F6-47A5-93CC-1D6E83849015Q47607217-1E7A4AE2-302B-47EE-8066-2AD05B0EE912Q47717692-F1E88D15-6C16-47D7-A4ED-24F7224F3CA9Q47780530-45D4D460-EBB3-470D-BC1D-0BBBCF19AE6CQ47976659-07384CA9-F0EB-4B06-924C-EF11E3F9ADF7Q48071341-9B4D44D8-7498-4C27-9ED5-48DF86310245Q48096183-29D59519-FED0-463D-A0E3-FF57B09917ACQ48338024-D85AA063-E175-4C31-B398-0542ABD3EC23Q49011558-543AD4A2-6EF4-47F3-AD7B-DB76757445A2Q50517238-C4A318D4-AEC0-4E76-83CA-F8D1F432B31CQ50618911-A16AA89C-5037-4698-A1B4-C07E83DE02E3Q50887639-122CBE53-6EF8-4BDD-9DF0-A2EF29CED712Q50891533-2342A40C-B19C-4E44-8968-5151AB0E9864Q51835868-05D8946F-49FE-4500-BDC2-533A1143B2CCQ51839558-2AA160DC-C090-4EBD-8C41-85C1EA98FDA6Q53158410-598B93F1-3136-41CC-8A19-4278DB8CDC23Q59441952-F8A1D494-68B5-4642-A88D-6133B87CAC46
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Torquil Watt
@ast
Torquil Watt
@en
Torquil Watt
@es
Torquil Watt
@nl
Torquil Watt
@sl
type
label
Torquil Watt
@ast
Torquil Watt
@en
Torquil Watt
@es
Torquil Watt
@nl
Torquil Watt
@sl
prefLabel
Torquil Watt
@ast
Torquil Watt
@en
Torquil Watt
@es
Torquil Watt
@nl
Torquil Watt
@sl
P106
P21
P31
P496
0000-0002-6001-7440